CONMED Corp — Director's Dealing 2018

Oct 29, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-10-26

Reporting Person: KENNEDY JOHN JED (VP GM CET)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-26	Common Stock	M	600	—	Acquired	3778	Direct
2018-10-26	Common Stock	F	177	$68.99	Disposed	3601	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-26	Rsus (restricted Stock Units)	$0	M	600	Disposed	2022-10-26	Common Stock (600)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year.